HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spinocerebellar ataxia 13

A hereditary autosomal dominant spinocerebellar ataxia with onset typically between 20 and 40 years of age. It is characterized by progressive childhood-onset cerebellar GAIT ATAXIA associated with cerebellar DYSARTHRIA, moderate INTELLECTUAL DISABILITY. Associated with mutations in the KCNC3 gene. OMIM: 605259
Also Known As:
Autosomal dominant cerebellar ataxia with mental retardation; Cerebellar ataxia, autosomal dominant with mental retardation; SCA13 Spinocerebellar ataxia 13
Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Nervous System Diseases (Neurological Disorders)

Experts

1. Waters, Michael F: 4 articles (10/2018 - 03/2011)
2. Nick, Harry S: 3 articles (10/2018 - 01/2013)
3. Khare, Swati: 2 articles (10/2018 - 11/2014)
4. Nick, Jerelyn A: 2 articles (10/2018 - 11/2014)
5. Subramony, S H: 2 articles (10/2018 - 01/2013)
6. Pulst, Stefan M: 2 articles (11/2014 - 03/2011)
7. Chan, Chung Yu: 1 article (01/2022)
8. Wu, Ling-Gang: 1 article (01/2022)
9. Galeano, Kira: 1 article (10/2018)
10. Kaczmarek, Leonard K: 1 article (10/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Spinocerebellar ataxia 13:
1. Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
2. Potassium Channels (Potassium Channel)IBA
3. Proteins (Proteins, Gene)FDA Link
4. DNA (Deoxyribonucleic Acid)IBA
5. Actins (F Actin)IBA